Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Filing lists "Zimmer Holdings, Inc." though metadata references "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K (Current Report)
Date of Report: October 24, 2013
Reporting Period: Quarter ended September 30, 2013
Context: The company reported its quarterly results of operations. The filing incorporates an earnings release (Exhibit 99.1) by reference, which contains the detailed financial data.
Key Financial Metrics
The provided Form 8-K text serves as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1 (Press Release), which is not included in the input text.
Non-GAAP Measures Discussed: The filing details the use of two types of non-GAAP measures in the attached press release:
- Constant Currency Sales: Calculated by translating actual current and prior-period sales at the same predetermined exchange rate to exclude foreign currency effects.
- Adjusted Operating Performance: Includes adjusted net earnings and adjusted diluted EPS. These exclude:
- Inventory step-up and other inventory/manufacturing charges.
- Provision for Durom Acetabular Component product claims.
- Special items (acquisition/integration costs, asset impairments, employee termination benefits, consulting fees, litigation, restructuring costs).
Material Changes
The filing text does not provide specific data on material changes in financial performance versus the prior comparable period. It only states that the company reported results for the quarter ended September 30, 2013, and that the press release contains year-over-year percentage increases or decreases on a constant currency basis.
Guidance, Outlook, and Risks
Guidance: The text mentions that the attached press release includes "projected adjusted diluted EPS," but does not state the specific guidance figures.
Management Commentary: Management utilizes the non-GAAP measures internally to evaluate business performance, identify operating trends masked by special items, and perform trend analysis. These measures are also used in incentive compensation programs.
Risks and Contingencies: The filing explicitly references the following items as exclusions in adjusted metrics, indicating they are material to the company's financials:
- Product claims related to Durom Acetabular Components.
- Asset impairment charges related to prior acquisitions and global restructuring.
- Certain litigation matters.
- Contract terminations.
Investor Verification Checklist
- Verify the specific GAAP and non-GAAP revenue, net earnings, and EPS figures in the attached Exhibit 99.1 (Press Release).
- Review the reconciliation of non-GAAP measures to GAAP measures to understand the magnitude of excluded items (e.g., Durom claims, restructuring costs).
- Confirm the specific projected adjusted diluted EPS guidance provided in the press release.
- Assess the impact of foreign currency exchange rates on reported sales growth by comparing constant currency vs. reported sales.
- Investigate the status and potential financial exposure of the Durom Acetabular Component product claims and ongoing litigation.